REFERENCES
- Morse R M, Flavin D K. The definition of alcoholism. JAMA. 1992; 268: 1012–1014
- Shedler J, Block J. Adolescent drug use and psychological health: a longitudinal inquiry. Am Psychologist. 1990; 45: 612–630
- Anton R F, O'Malley S S, Ciraulo D A, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA 2006; 295: 2003–2017
- Garbutt J C, Kranzler H R, O'Malley S S, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence. JAMA 2005; 293: 1617–1625
- Bouza C, Angeles M, Munoz A, Amate J M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004; 99: 811–828
- Domino K B, Hornbein T F, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005; 293: 1453–1460
- Flynn C F, Sturges M S, Swarsen R J, Kohn G M. Alcoholism and treatment in airline aviators: one company's results. Aviat Space Environ Med 1993; 64: 31–38
- Bouza C, Angeles M, Munoz A, Amate J M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004; 99: 811–828
- Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2005; 8: 267–280
- Mann K, Lehert P, Morgan M Y. The Efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 2004; 28: 51–63
- Naylor C D. Meta-analysis and the meta-epidemiology of clinical research. BMJ 1997; 315: 617–619
- Anton R F, O'Malley S S, Ciraulo D A, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study—a randomized controlled trial. JAMA 2006; 295: 2003–2017
- Johnson B A, It-Daoud N, Bowden C L, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003; 361: 1677–1685
- Johnson B A, Rosenthal N, Capece J, et al. Topiramate for the treatment of alcohol dependence: results from a multi-site trial. Alcohol Clin Exp Res 2007; 31(s2)261A
- Grant B F, Harford T C, Muthen B O, Yi H, Hasin D S, Stinson F S. DSM-IV alcohol dependence and abuse: further evidence of validity in the general population. Drug Alcohol Depend 2007; 86: 154–166
- Hasin D S, Liu X, Alderson D, Grant B F. DSM-IV alcohol dependence: a categorical or dimensional phenotype?. Psychol Med 2006; 36: 1695–1705
- Russell J C, Davis A W. Alcohol Rehabilitation of Airline Pilots. Federal Aviation Administration, Office of Aviation Medicine, Washington, DC 1985, NTIS Technical Report AD-A163076
- Wright C, Grodin D M, Harig P T. Occupational outcome after military treatment for alcoholism. J Occup Med. 1990; 32: 24–32
- Dawson D A, Grant B F, Li T K. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res 2005; 29: 902–908
- Dawson D A. Alcohol consumption, alcohol dependence, and all-cause mortality. Alcohol Clin Exp Res 2000; 24: 72–81
- Cisler R A, Kowalchuk R K, Saunders S M, Zweben A, Trinh H Q. Applying clinical significance methodology to alcoholism treatment trials: determining recovery outcome status with individual-and population-based measures. Alcohol Clin Exp Res 2005; 29: 1991–2000